Discussion: In this study, the results will provide credible evidence to assess the efficacy and safety of acupuncture therapies for elderly patients with insomnia disorder, assisting patients, physicians and clinical research investigators to select the most appropriate acupuncture method.

Therapeutic Advance: Daridorexant is a novel agent with demonstrated efficacy in sleep onset and maintenance and decrease in daytime sedation. Preliminary results from a 1-year extension study note similar incidences of mild-to-moderate side effects as noted in previous trials. Further studies are needed to establish its place in the...

To the Editor: As sleep specialists, we wish to comment on the recent letter by Nobile et al, which suggests a potential role for daridorexant, a new hypnotic, in increasing suicide risk.

Conclusions/Relevance: Treatment of insomnia with Daridorexant as a Dual Orexin Receptor Antagonist (DORA) has been evaluated in several preclinical and clinical studies. Available information obtained from those studies has shown a promising future for this drug in the management of insomnia

Abstract: This is a summary of the original article ‘Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)’. Individuals with insomnia are best positioned to assess the impact of insomnia on their quality of life. Patient reported outcomes (PROs) are self-reported health measures created to allow...